Presenting features of patients included in this analysis
Feature . | No. of cases in each group . |
|---|---|
| Male/female (ratio) | 1034/906 (1.14/1.00) |
| Etiology | |
| De novo AML | 1614 |
| s-AML | 201 |
| t-AML | 125 |
| FAB classification | |
| M0 | 80 |
| M1 | 332 |
| M2 | 693 |
| M3/M3v | 87 |
| M4 | 327 |
| M4eo | 97 |
| M5 | 156 |
| M6 | 78 |
| M7 | 10 |
| N/A | 80 |
| Karyotype | |
| Normal | 908 |
| t(15;17) | 84 |
| t(8;21) | 76 |
| inv(16)/t(16;16) | 97 |
| t(11q23)/MLL | 65 |
| inv(3)/t(3;3) | 39 |
| t(6;9) | 5 |
| –5/del(5q) | 20 |
| –7/del(7q) | 35 |
| Trisomy 8 | 81 |
| Trisomy 11 | 12 |
| Complex aberrant | 236 |
| All others | 255 |
| Not analyzed | 27 |
Feature . | No. of cases in each group . |
|---|---|
| Male/female (ratio) | 1034/906 (1.14/1.00) |
| Etiology | |
| De novo AML | 1614 |
| s-AML | 201 |
| t-AML | 125 |
| FAB classification | |
| M0 | 80 |
| M1 | 332 |
| M2 | 693 |
| M3/M3v | 87 |
| M4 | 327 |
| M4eo | 97 |
| M5 | 156 |
| M6 | 78 |
| M7 | 10 |
| N/A | 80 |
| Karyotype | |
| Normal | 908 |
| t(15;17) | 84 |
| t(8;21) | 76 |
| inv(16)/t(16;16) | 97 |
| t(11q23)/MLL | 65 |
| inv(3)/t(3;3) | 39 |
| t(6;9) | 5 |
| –5/del(5q) | 20 |
| –7/del(7q) | 35 |
| Trisomy 8 | 81 |
| Trisomy 11 | 12 |
| Complex aberrant | 236 |
| All others | 255 |
| Not analyzed | 27 |
N = 1940. Median age was 60 years (range, 15-90 years).